La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Australian Clinical Labs Gestion
Gestion contrôle des critères 4/4
Australian Clinical Labs' CEO is Melinda McGrath, appointed in Dec 2020, has a tenure of 3.67 years. total yearly compensation is A$1.18M, comprised of 74.2% salary and 25.8% bonuses, including company stock and options. directly owns 1.46% of the company’s shares, worth A$7.51M. The average tenure of the management team and the board of directors is 5.1 years and 3.3 years respectively.
Informations clés
Melinda McGrath
Directeur général
AU$1.2m
Rémunération totale
Pourcentage du salaire du PDG | 74.2% |
Durée du mandat du directeur général | 3.7yrs |
Propriété du PDG | 1.5% |
Durée moyenne d'occupation des postes de direction | 5.1yrs |
Durée moyenne du mandat des membres du conseil d'administration | 3.3yrs |
Mises à jour récentes de la gestion
Recent updates
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt
Jun 20Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?
Feb 21Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?
Dec 08Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today
Aug 14Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)
Dec 22The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More
Dec 21The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business
Sep 01Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Dec 31 2023 | n/a | n/a | AU$15m |
Sep 30 2023 | n/a | n/a | AU$26m |
Jun 30 2023 | AU$1m | AU$873k | AU$36m |
Mar 31 2023 | n/a | n/a | AU$55m |
Dec 31 2022 | n/a | n/a | AU$73m |
Sep 30 2022 | n/a | n/a | AU$126m |
Jun 30 2022 | AU$2m | AU$873k | AU$178m |
Mar 31 2022 | n/a | n/a | AU$156m |
Dec 31 2021 | n/a | n/a | AU$134m |
Sep 30 2021 | n/a | n/a | AU$97m |
Jun 30 2021 | AU$2m | AU$875k | AU$60m |
Mar 31 2021 | n/a | n/a | AU$79m |
Dec 31 2020 | n/a | n/a | AU$98m |
Sep 30 2020 | n/a | n/a | AU$70m |
Jun 30 2020 | AU$2m | AU$852k | AU$41m |
Rémunération vs marché: Melinda's total compensation ($USD789.76K) is about average for companies of similar size in the Australian market ($USD838.87K).
Rémunération et revenus: Melinda's compensation has been consistent with company performance over the past year.
PDG
Melinda McGrath
3.7yrs
Titularisation
AU$1,175,644
Compensation
Ms. Melinda McGrath is Chief Executive Officer and Executive Director at Australian Clinical Labs Limited since December 19, 2020. She served as Chief Executive Officer and Executive Director at Clinical L...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO & Executive Director | 3.7yrs | AU$1.18m | 1.46% A$ 7.5m | |
Deputy Chief Financial Officer | less than a year | pas de données | pas de données | |
Chief Operating Officer | 8.6yrs | pas de données | 0.38% A$ 1.9m | |
Chief Information Officer | 9.6yrs | pas de données | pas de données | |
National Marketing Director | no data | pas de données | pas de données | |
National Medical Director & Chief Pathologist | 15.6yrs | pas de données | 0.42% A$ 2.2m | |
Chief Executive Officer of New South Wales & Australian Capital Territory | 13.6yrs | pas de données | pas de données | |
Chief Executive Officer of WA/SA/NT | 6.6yrs | pas de données | pas de données | |
Company Secretary | 3.3yrs | pas de données | pas de données | |
Chief Executive Officer of ACL Commercial Pathology | 1.6yrs | pas de données | pas de données | |
Chief Executive Officer of Victoria | 1.6yrs | pas de données | pas de données |
5.1yrs
Durée moyenne de l'emploi
Gestion expérimentée: ACL's management team is seasoned and experienced (5.1 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO & Executive Director | 3.7yrs | AU$1.18m | 1.46% A$ 7.5m | |
Non-Executive Chairman | less than a year | AU$190.00k | 0.14% A$ 720.9k | |
Independent Non-Executive Director | less than a year | pas de données | 0.010% A$ 51.4k | |
Independent Non-Executive Director | 3.3yrs | AU$145.66k | 0.041% A$ 210.5k | |
Non Executive Director | 3.7yrs | AU$130.00k | pas de données | |
Independent Non-Executive Director | 3.3yrs | AU$140.64k | 0.0025% A$ 12.8k | |
Independent Non-Executive Director | 3.3yrs | AU$145.66k | 0.024% A$ 122.1k |
3.3yrs
Durée moyenne de l'emploi
64yo
Âge moyen
Conseil d'administration expérimenté: ACL's board of directors are considered experienced (3.3 years average tenure).